These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29576621)

  • 1. The mechanism study of lentiviral vector carrying methioninase enhances the sensitivity of drug-resistant gastric cancer cells to Cisplatin.
    Xin L; Yang WF; Zhang HT; Li YF; Liu C
    Br J Cancer; 2018 May; 118(9):1189-1199. PubMed ID: 29576621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. METase/lncRNA HULC/FoxM1 reduced cisplatin resistance in gastric cancer by suppressing autophagy.
    Xin L; Zhou Q; Yuan YW; Zhou LQ; Liu L; Li SH; Liu C
    J Cancer Res Clin Oncol; 2019 Oct; 145(10):2507-2517. PubMed ID: 31485766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronic acid-modified polyamidoamine dendrimer G5-entrapped gold nanoparticles delivering METase gene inhibits gastric tumor growth via targeting CD44+ gastric cancer cells.
    Li YF; Zhang HT; Xin L
    J Cancer Res Clin Oncol; 2018 Aug; 144(8):1463-1473. PubMed ID: 29858680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RKIP promotes cisplatin-induced gastric cancer cell death through NF-κB/Snail pathway.
    Liu H; Li P; Li B; Sun P; Zhang J; Wang B; Jia B
    Tumour Biol; 2015 Mar; 36(3):1445-53. PubMed ID: 25547433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular mechanism of cisplatin to enhance the ability of TRAIL in reversing multidrug resistance in gastric cancer cells].
    Zhu X; Zhang K; Wang Q; Chen S; Gou Y; Cui Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):404-11. PubMed ID: 26463141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MLH1 enhances the sensitivity of human endometrial carcinoma cells to cisplatin by activating the MLH1/c-Abl apoptosis signaling pathway.
    Li Y; Zhang S; Wang Y; Peng J; Fang F; Yang X
    BMC Cancer; 2018 Dec; 18(1):1294. PubMed ID: 30594176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methioninase Gene Therapy.
    Hoffman RM; Miki K; Al-Refaie W; Xu M; Tan Y
    Methods Mol Biol; 2019; 1866():173-197. PubMed ID: 30725416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-494 Sensitizes Gastric Cancer Cells to TRAIL Treatment Through Downregulation of Survivin.
    Xu S; Li D; Li T; Qiao L; Li K; Guo L; Liu Y
    Cell Physiol Biochem; 2018; 51(5):2212-2223. PubMed ID: 30537730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methionine represses the autophagy of gastric cancer stem cells via promoting the methylation and phosphorylation of RAB37.
    Xin L; Li SH; Liu C; Zeng F; Cao JQ; Zhou LQ; Zhou Q; Yuan YW
    Cell Cycle; 2020 Oct; 19(20):2644-2652. PubMed ID: 32926650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibitory effect of E2F-1-silencing lentivirus vector on chemoresistance of subcutaneous human gastric cancer in nude mice].
    Kong FB; Wang XT; Xie YB; Xiao Q
    Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):655-9. PubMed ID: 24332051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin induces chemoresistance through the PTGS2-mediated anti-apoptosis in gastric cancer.
    Lin XM; Li S; Zhou C; Li RZ; Wang H; Luo W; Huang YS; Chen LK; Cai JL; Wang TX; Zhang QH; Cao H; Wu XP
    Int J Biochem Cell Biol; 2019 Nov; 116():105610. PubMed ID: 31518663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of E2F1 in human gastric carcinoma is involved in anti-cancer drug resistance.
    Yan LH; Wei WY; Cao WL; Zhang XS; Xie YB; Xiao Q
    BMC Cancer; 2014 Dec; 14():904. PubMed ID: 25466554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.
    Cheng C; Qin Y; Zhi Q; Wang J; Qin C
    Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic antitumor effect of AAV-mediated TRAIL expression combined with cisplatin on head and neck squamous cell carcinoma.
    Jiang M; Liu Z; Xiang Y; Ma H; Liu S; Liu Y; Zheng D
    BMC Cancer; 2011 Feb; 11():54. PubMed ID: 21291526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-421 regulated by HIF-1α promotes metastasis, inhibits apoptosis, and induces cisplatin resistance by targeting E-cadherin and caspase-3 in gastric cancer.
    Ge X; Liu X; Lin F; Li P; Liu K; Geng R; Dai C; Lin Y; Tang W; Wu Z; Chang J; Lu J; Li J
    Oncotarget; 2016 Apr; 7(17):24466-82. PubMed ID: 27016414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA SNHG5 promotes cisplatin resistance in gastric cancer via inhibiting cell apoptosis.
    Li M; Zhang YY; Shang J; Xu YD
    Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4185-4191. PubMed ID: 31173289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel enhances tumoricidal potential of TRAIL via inhibition of MAPK in resistant gastric cancer cells.
    Li L; Wen XZ; Bu ZD; Cheng XJ; Xing XF; Wang XH; Zhang LH; Guo T; Du H; Hu Y; Fan B; Ji JF
    Oncol Rep; 2016 May; 35(5):3009-17. PubMed ID: 26986870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT3/NF-κB-Regulated Lentiviral TK/GCV Suicide Gene Therapy for Cisplatin-Resistant Triple-Negative Breast Cancer.
    Kuo WY; Hwu L; Wu CY; Lee JS; Chang CW; Liu RS
    Theranostics; 2017; 7(3):647-663. PubMed ID: 28255357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance.
    Zhang XW; Bu P; Liu L; Zhang XZ; Li J
    Biochem Biophys Res Commun; 2015 Jul; 462(3):227-32. PubMed ID: 25956062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parthenolide, an NF-κB inhibitor, suppresses tumor growth and enhances response to chemotherapy in gastric cancer.
    Sohma I; Fujiwara Y; Sugita Y; Yoshioka A; Shirakawa M; Moon JH; Takiguchi S; Miyata H; Yamasaki M; Mori M; Doki Y
    Cancer Genomics Proteomics; 2011; 8(1):39-47. PubMed ID: 21289336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.